1-4 of 4
interleukin-12
Close
Sort by
Journal Articles

Immunomodulatory drugs suppress Th1-inducing ability of dendritic cells but enhance Th2-mediated allergic responses

Vien Phan, Tomoki Ito, Muneo Inaba, Yoshiko Azuma, Kayoko Kibata, Noriko Inagaki-Katashiba, Akihiro Tanaka, Atsushi Satake, Shosaku Nomura
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3572–3585.
https://doi.org/10.1182/bloodadvances.2019001410
Published: 2020
Includes: Supplemental data
Journal Articles

TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine

Derek Hoi-Hang Ho, Roger Hoi-Fung Wong
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1664–1679.
https://doi.org/10.1182/bloodadvances.2017013433
Published: 2018
Includes: Supplemental data
Journal Articles

Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells

Ana Raykova, Paolo Carrega, Frank M. Lehmann, Robert Ivanek, Vanessa Landtwing, Isaak Quast, Jan D. Lünemann, Daniela Finke, Guido Ferlazzo, Obinna Chijioke, Christian Münz
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2679–2691.
https://doi.org/10.1182/bloodadvances.2017008839
Published: 2017
Includes: Supplemental data
Journal Articles

IL-33, IL-25, and TSLP induce a distinct phenotypic and activation profile in human type 2 innate lymphoid cells

Ana Camelo, Guglielmo Rosignoli, Yoichiro Ohne, Ross A. Stewart, Catherine Overed-Sayer, Matthew A. Sleeman, Richard D. May
Journal: Blood Advances
Blood Adv (2017) 1 (10): 577–589.
https://doi.org/10.1182/bloodadvances.2016002352
Published: 2017
Includes: Supplemental data